Pantroprazole (Adco Pantoprazole Iv)

Pantroprazole

Adcock Ingram Critical Care (Pty) Ltd

Registration

Applicant: Adcock Ingram Critical Care (Pty) Ltd
Certificate holder: Adcock Ingram Critical Care (Pty) Ltd
Registrations: 1

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Adco pantoprazole iv EACH 15,0 ml SOLUTION CONTAINS :PANTOPRAZOLE SODUIM SESQUIHYDRATE EQUIVALENT TO PANTROPRAZOLE 40,0 mg	40mgTablet. Oral solution	44098144/11.4.3/0981Approved 23 September 2021	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

This product's active ingredient could not be matched to a single known compound.

SAHPRA documents

Professional information (PI)For healthcare professionals Patient information leaflet (PIL)For patients and carers

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading Wikipedia summary

Research articles

Loading PubMed articles